Day: October 13, 2023

Omaha, NE, Oct. 13, 2023 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that on October 10, 2023, it successfully closed the acquisition of substantially all of the assets of MusclePharm Corporation (“MusclePharm”) as previously approved by the US Bankruptcy Court for the District of Nevada.  Through the asset purchase transaction under Section 363 of the US Bankruptcy Code, the Company acquired substantially all of the assets and assumed none of the liabilities of MusclePharm other than de minimus cure costs relating to certain assumed contracts.  Total consideration for the acquisition was approximately $18.5 million cash.  Of this amount, $10.0 million was funded using proceeds from a...

BRIDGEVILLE, Pa., Oct. 13, 2023 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) today announced a base price increase of 5% to 10% on premium products. The increase goes into effect immediately. Current material and energy surcharges will remain in effect. Brian Kane, Vice President Sales & Marketing, commented: “Supply chain cost pressures persist. The price adjustment is necessary to mitigate the realized cost burden while continuing to invest in equipment and technologies to remain globally competitive.” About Universal Stainless & Alloy Products, Inc. Universal Stainless & Alloy Products, Inc., established in 1994 and headquartered in Bridgeville, PA, manufactures and markets semi-finished and finished specialty steels, including stainless steel, nickel alloys, tool steel and...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, 2021. MONTREAL, Oct. 13, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced results from a study evaluating an intramuscular (IM) method of administration for Trogarzo® (ibalizumab-uiyk), a monoclonal antibody antiretroviral therapy (ART) for the treatment of heavily treatment-experienced adults with multidrug-resistant (MDR) HIV-1 infection failing their current antiretroviral regimen. The TMB-302 study, conducted in partnership with TaiMed Biologics, enrolled...

CAAC Issued the EH216-S Type Certificate to EHangCAAC Issued the EH216-S Type Certificate to EHangGUANGZHOU, China, Oct. 13, 2023 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company, announced that the EH216-S, its self-developed passenger-carrying unmanned aerial vehicle (“UAV”) system, has obtained the type certificate (“TC”) officially issued by the Civil Aviation Administration of China (“CAAC”). This demonstrates that the EH216-S’s model design fully complies with CAAC’s safety standards and airworthiness requirements, and that the EH216-S is qualified for conducting passenger-carrying UAV commercial operations. As the world’s first TC for unmanned electric vertical take-off and landing aircraft (“eVTOL”), the...

Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The partners have signed a collaborative research agreement with the purpose of testing PCI Biotech’s proprietary technology for gene therapy manufacturing in the partners’ pilot manufacturing process. PCI Biotech brings its novel and promising technology for viral vector manufacturing into the field testing, while the partner provides facilities and expertise, as well as feedback on performance and usability of the technology, to guide PCI Biotech’s future development. The research collaboration agreement includes an option to mutually determine a potential future business transaction. The undisclosed partner is a European entity, part of an international...

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeRestaurant Group plc (The)(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to Restaurant Group plc (The)(d)        Date dealing undertaken: 12th October 2023(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer...

Meriaura Group Plc Company announcement, Insider information                  13 October at 8.30 am (CEST) Inside information: Meriaura Energy – Savosolar’s solar thermal system delivery to Bauer Holzenergie in Bad Rappenau, Germany, begins In June, Meriaura Energy Oy – Savosolar signed a contract with Bauer Holzenergie GmbH u. Co.KG for the turnkey delivery of a solar thermal system worth approximately 9 million euros to Bad Rappenau, Germany. The delivery contract was conditional on a building permit. The parties have agreed to start the project after a delay in the building permit process. The delivery of the solar thermal system will commence immediately, and its commissioning will take place in 2024. Kirsi Suopelto, CEO of Meriaura Group Oyj: “We are pleased that our system design and project management teams...